Fidaxomicin’s Role in Overcoming Vancomycin Failure in Clostridium difficile Infections: A Case Series and Literature Review
<i>Clostridium difficile</i> infection (CDI), characterized by diarrheal illness with serious complications, is a common pathology in clinical practice. We present a series of five patients with CDI who underwent treatment with fidaxomicin following the failure of oral vancomycin. To our knowledge, no evidence in the literature suggests that fidaxomicin is more effective than vancomycin in treating acute infection. This paper emphasizes the importance of utilizing a large study to determine the relative effectiveness of vancomycin versus fidaxomicin in treating CDI. We also provide a literature review on CDI and management evolution.
Authors
- Mohammad Kloub (ORCID: https://orcid.org/0000-0001-7115-7353)
- Jihad Slim (ORCID: https://orcid.org/0000-0002-4192-7246)
- Mohammad Nabil Rayad
- Qusai Al-maharmeh
- Bereket Tewoldemedhin
- Yazeed Abu Ruman
- Ahmad W Haddad
- Shefali Pati
Institutions
- Saint Michael's Medical Center (US)
Publication Details
- Journal
- Cureus
- Published
- 2025-03-24
- DOI
- https://doi.org/10.7759/cureus.81110
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00